Stocks were in the red through to the end of the day on Tuesday after sales warnings from Caterpillar and Under Armour spooked investors.
With a pair of Phase III trials coming up for its dermatological drug, Novan CEO Nate Stasko says the company is merely piercing the skin of its long-term potential.
If Hillary Clinton garners more than 50% of the popular vote come November 8, she'll be overcoming a hurdle her husband never did.
Don't expect a Clinton "relief rally" because the markets have considered her the favorite all along,
Consumer confidence takes a hit in October, due to rising prices and the upcoming election, according to one economist.
Jim Cramer shares his latest take on shares of Lululemon Athletica.
What should investors expect from Tesla's upcoming quarterly results?
Shares of Under Armour were lower Tuesday despite posting an earnings beat for the quarter.